IINN
Inspira Technologies Oxy B.H.N. Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$1.05
−0.94%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 289.0K | 289.0K | — | — | (4.7M) |
| Cost of Revenue | 287.0K | 561.0K | 488.0K | 406.0K | 361.0K |
| Gross Profit | 2.0K | (272.0K) | (488.0K) | (406.0K) | (5.0M) |
| Operating Expenses | |||||
| R&D Expense | 6.9M | 7.2M | 6.3K | 7.0M | 8.1M |
| SG&A Expense | 6.1M | 6.2M | 4.8M | 4.7M | 6.7M |
| General & Admin Expense | 5.3M | — | 3.8M | 3.7M | 5.4M |
| Selling & Marketing Expense | 791.0K | — | 754.0K | 746.0K | 1.3M |
| Other Expenses | (26.1M) | — | (4.8M) | — | (176.0K) |
| Total Operating Expenses | (13.0M) | 13.3M | (11.3K) | 11.7M | 14.6M |
| Cost and Expenses | (12.8M) | 13.9M | (11.3K) | 12.1M | 14.9M |
| Operating Income (EBIT) | 13.0M | (13.6M) | 11.3K | (12.1M) | 14.9M |
| Non-Operating | |||||
| Interest Income | 120.0K | 64.0K | 173.0K | 318.0K | 4.7M |
| Interest Expense | — | 9.0K | — | 10.0K | 181.0K |
| Net Interest Income | 120.0K | 55.0K | 173.0K | 308.0K | 4.5M |
| Other Non-Op Income/Expense | (25.7M) | 394.0K | (22.3K) | 847.0K | (29.9M) |
| Non-Operating Income (excl Interest) | 26.1M | — | 22.5K | (857.0K) | 29.8M |
| EBT (Pre-Tax Income) | (12.6M) | (13.2M) | (11.1K) | (11.3M) | (15.0M) |
| Income Tax Expense | — | — | — | — | (6.3M) |
| Bottom Line | |||||
| Net Income | (12.6M) | (13.2M) | (11.1K) | (11.3M) | (4.0M) |
| Earnings from Cont. Ops | (12.6M) | (13.2M) | (11.1K) | (11.3M) | (4.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (12.6M) | (13.2M) | (11.1K) | (11.3M) | (15.0M) |
| Per Share | |||||
| Basic EPS | ($0.62) | ($0.45) | ($0.00) | ($0.93) | ($1.39) |
| Diluted EPS | ($0.62) | ($0.45) | ($0.00) | ($0.93) | ($1.39) |
| Revenue Per Share | $0.01 | $0.01 | $0.00 | $0.00 | ($0.43) |
| Shares | |||||
| Basic Shares Outstanding | 26.8M | 29.6M | 18.5M | 12.1M | 10.8M |
| Diluted Shares Outstanding | 26.8M | 29.6M | 18.5M | 12.1M | 10.8M |
| Profitability Metrics | |||||
| EBITDA | (12.9M) | (13.2M) | (11.1K) | (10.9M) | (14.7M) |
| D&A | 140.0K | 449.0K | 171.00 | 406.0K | 292.0K |
| EBIT | (13.0M) | (13.6M) | (11.3K) | (11.3M) | (15.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025